Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. is classed by the SEC under Services-Commercial Physical & Biological Research (industry code 8731), based in Wilmington, MA. In its latest annual figures on file, for the fiscal year ended 2025-12-27, it reported revenue of $4.0 billion and a loss of $144 million (its filed statements).
vs its business-model standard
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a project business: prior from its industry code (SEC 8731, Services-Commercial Physical & Biological Research); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 5.1 out of ten, 9 of 9 metrics filed: past 5.8 out of ten, present 5.1 out of ten, future 4.1 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
- Surviving crises (past): 7.9 out of ten. No warning events in its filings since 2017. 79th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Track record (past): 6.0 out of ten. +10.2% a year over 10 filed years; profitable in 9 of 10. 60th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Shareholder treatment (past): 2.3 out of ten. Share count shrank 1.1% a year. 23% of cash flow returned. Insiders: 19 sales, 2 purchases. 23rd percentile among 6 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Financial health (present): 5.0 out of ten. ROE -4%: lost 4¢ per shareholder dollar. Leverage 56%: owes 56¢ per asset dollar. 50th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Industry position (present): 5.7 out of ten. top 43% of 12 in its family; net margin -3.5%. 57th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Leadership (present): 3.8 out of ten. bottom 38% of 8 in its family for leadership; chief executive since 2026. 38th percentile among 8 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
- Room to expand (future): 5.0 out of ten. top 50% of 12 in its family for room to expand. 50th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Growth drivers (future): 4.6 out of ten. bottom 46% of 12 in its family for growth drivers. 46th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Expectations vs reality (future): 2.6 out of ten. bottom 26% of 11 in its family for expectations against reality. 26th percentile among 11 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-18 for the period ended 2025-12-27 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-05 for the period ended 2026-06-27 (on EDGAR). Newest results release: Form 8-K filed 2026-08-05 (on EDGAR). Newest filing: Form 4, 2026-10-07. Filings on record since 1999. Read from EDGAR 2026-10-12.
Where the revenue comes from
Lines of business in fiscal 2025: Discovery and Safety Assessment 60%, Research Models and Services 21%, Manufacturing Support 19%. By geography: United States 53%, Europe 28%, Canada 13%, Asia Pacific 5%, Other 2%. As tagged in its annual report (Form 10-K, filed 2026-02-18).
Who runs it
Foster, James C (Chairman, President and CEO); Girshick, Birgit (Chief Executive Officer); Coleman, Glenn (EVP & Chief Financial Officer); Creamer, Victoria L (EVP & Chief People Officer); Mintz, Mark (EVP, Chief Information Officer); Parisotto, Shannon M (CEVP, Disc & Safety Assessment); Laplume, Joseph W (EVP, Corp Strategy & Develop); Knell, Michael Gunnar (SVP, Finance and CAO); Andrews, Nancy C (director); Barg, Steven (director); and 8 more. 18 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-10-07.
This file: Overview · Past · Present · Future · Filings · every company on file
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.